## 3 Results
### Endocrine Parameters
\begin{table}
\begin{tabular}{c c c c c c c c} \hline \hline  & \multicolumn{2}{c}{**High Adherence to ADLP**} & \multicolumn{2}{c}{**Middle Adherence to ADLP**} & \multicolumn{2}{c}{**Low Adherence to ADLP**} \\ \cline{2-7}  & \(n\) & **OR (CI95\%), _p_** & \(n\) & **OR (CI95\%), _p_** & \(n\) & **OR (CI95\%), _p_** \\ \hline BMI \(>30\) kg/m\({}^{2}\) & 11 & 1.83 (0.74; 4.53), \(p\) = 0.18 & 9 & 1.35 (0.53; 3.41), \(p\) = 0.52 & 4 & 1.09 (0.42; 2.81), \(p\) = 0.80 \\ BMI \(>25\) kg/m\({}^{2}\) & 23 & 1.39 (0.68; 2.87), \(p\) = 0.36 & 23 & 1.67 (0.80; 3.46), \(p\) = 0.16 & 14 & 0.87 (0.41; 1.81), \(p\) = 0.70 \\ WHR \(>0.80\) & 24 & 1.34 (0.64; 2.78), \(p\) = 0.43 & 21 & 1.22 (0.58; 2.57), \(p\) = 0.60 & 18 & 0.84 (0.40; 1.78), \(p\) = 0.65 \\ WHR \(>0.5\) & 21 & 1.20 (0.58; 2.48), \(p\) = 0.62 & 24 & 2.37 (112; 5.01), \(p\) = 0.02 * & 12 & 0.97 (0.46; 2.03), \(p\) = 0.93 \\ Fat \(>35\)\% & 24 & 0.97 (0.47; 1.99), \(p\) = 0.94 & 29 & 2.71 (1.27; 5.77), \(p\) = 0.01 * & 16 & 1.60 (0.77; 3.33), \(p\) = 0.21 \\ Cholesterol \(>200\) mg/dL & 13 & 2.35 (0.93; 5.89), \(p\) = 0.07 & 4 & 0.32 (0.10; 1.06), \(p\) = 0.06 & 9 & 1.82 (0.72; 4.63), \(p\) = 0.20 \\ LDL \(>135\) mg/dL & 6 & 2.51 (0.70; 9.05), \(p\) = 0.15 & 1 & 0.20 (0.2; 1.68), \(p\) = 0.13 & 4 & 1.23 (0.33; 4.63), \(p\) = 0.75 \\ HDL \(<50\) mg/dL & 8 & 1.65 (0.60; 4.58), \(p\) = 0.32 & 7 & 1.42 (0.50; 4.01), \(p\) = 0.50 & 3 & 1.88 (0.68; 5.22), \(p\) = 0.22 \\ TG \(>150\) mg/dL & 5 & 1.39 (0.40; 4.84), \(p\) = 0.60 & 5 & 1.78 (0.50; 6.31), \(p\) = 0.36 & 3 & 1.60 (0.46; 5.60), \(p\) = 0.46 \\ HOMA \(>2.5\) & 18 & 1.03 (0.49; 2.18), \(p\) = 0.92 & 17 & 1.21 (0.58; 2.48), \(p\) = 0.61 & 15 & 1.09 (0.53; 2.27), \(p\) = 0.80 \\ Fasting glue: \(>100\) mg/dL & 5 & 1.28 (0.33; 4.96), \(p\) = 0.71 & 1 & 0.22 (0.33; 1.92), \(p\) = 0.17 & 4 & 0.88 (0.21; 3.76), \(p\) = 0.81 \\ Fasting ins. \(>10\) mV/mL & 26 & 1.52 (0.75; 3.12), \(p\) = 0.24 & 21 & 1.05 (0.51; 2.17), \(p\) = 0.88 & 18 & 1.10 (0.53; 2.27), \(p\) = 0.79 \\ LH \(>\) upper tertile & 16 & 1.35 (0.63; 2.92), \(p\) = 0.43 & 11 & 0.70 (0.31; 1.61), \(p\) = 0.40 & 14 & 1.00 (0.47; 2.12), \(p\) = 0.99 \\ FSH \(>\) upper tertile & 14 & 0.93 (0.37; 2.09), \(p\) = 0.87 & 12 & 0.94 (0.41; 2.12), \(p\) = 0.88 & 14 & 1.10 (0.49; 2.48), \(p\) = 0.80 \\ LH/ FSH \(>\) upper tertile & 16 & 1.28 (0.59; 2.77), \(p\) = 0.52 & 12 & 0.79 (0.35; 1.77), \(p\) = 0.57 & 14 & 0.80 (0.36; 1.80), \(p\) = 0.60 \\ T \(>\) upper tertile & 18 & 1.20 (0.57; 2.55), \(p\) = 0.62 & 13 & 0.77 (0.35; 1.69), \(p\) = 0.51 & 16 & 1.06 (0.49; 2.29), \(p\) = 0.87 \\ A \(>\) upper tertile & 17 & 1.17 (0.56; 2.47), \(p\) = 0.67 & 14 & 1.57 (0.47; 5.26), \(p\) = 0.46 & 16 & 1.01 (0.47; 2.17), \(p\) = 0.96 \\ DHEA\(<\)s\(>\) upper tertile & 16 & 1.02 (0.48; 2.17), \(p\) = 0.95 & 18 & 1.48 (0.70; 3.13), \(p\) = 0.30 & 13 & 0.75 (0.34; 1.64), \(p\) = 0.47 \\ PCs type 1 & 31 & 2.10 (1.00; 4.40), \(p\) = 0.04 * & 18 & 0.46 (0.22; 0.96), \(p\) = 0.04 * & 25 & 1.83 (0.85; 3.90), \(p\) = 0.11 \\ PCs type 2 & 6 & 0.47 (0.16; 1.39), \(p\) = 0.17 & 13 & 3.47 (1.37; 8.82), \(p\) = 0.00 * & 5 & 0.58 (0.19; 1.69), \(p\) = 0.31 \\ PCs type 3 & 3 & 0.55 (0.14; 2.14), \(p\) = 0.39 & 5 & 1.35 (0.41; 4.44), \(p\) = 0.62 & 5 & 0.65 (0.17; 2.56), \(p\) = 0.54 \\ PCs type 4 & 8 & 0.77 (0.30; 1.94), \(p\) = 0.58 & 8 & 0.86 (0.34; 2.17), \(p\) = 0.75 & 11 & 0.75 (0.29; 1.96), \(p\) = 0.56 \\ \hline \hline \end{tabular} Abbreviations: BMI—Body Mass Index, WHR—Waist-to-Hip Ratio, WHR—Waist-to-Height Ratio, T. Chol—total cholesterol; HDL—High-density lipoprotein, LDL—Low-density lipoprotein, TG—Triglycerides, HOMA-IR—Homostatic Model Assessment—Insulin Resistance, Fasting glucce, Fasting ins.—fasting insulin, DHEA—Dehydrogiandrosterno sulfate. The \(p\) values below the threshold of statistical significance are marked with the \({}^{*}p<0.05\).  
\end{table} 
Table 4: The adherence to the active dietary-lifestyle pattern (DLP) and it’s relation with different metabolic and endocrine markers.